B · Normal
On September 12, AstraZeneca’s U.S. stocks fell 2% after the market closed due to disappointing results from the Phase III clinical trial.
Related telegraphs
On September 22, Angpao’s stock price continued to rise at the beginning of the
09-22 21:41
September 22nd, Shopify’s stock price rose by more than 15% in the past two days
09-22 21:33
On September 22, Swiss sports brand Angpa opened with a 9% increase, the largest
09-22 21:32
[Apple’s new Mac mini and Mac Studio are on the market today] On September 22, A
09-22 21:13
September 22 (Xinhua) Bamboo, a home insurance company backed by private equity
09-22 21:11
On September 22, Oppenheimer maintained Microsoft's "outperform" rating and rais
09-22 20:56
Comments